ST红太阳(000525) - 2020 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2020 was ¥735,873,844.81, a decrease of 40.33% compared to ¥1,233,224,878.97 in the same period last year[8] - The net profit attributable to shareholders was ¥7,695,081.96, down 93.60% from ¥120,177,826.39 year-on-year[8] - The net profit after deducting non-recurring gains and losses was -¥47,060,511.32, representing a decline of 145.34% compared to ¥103,800,469.54 in the previous year[8] - Basic earnings per share were ¥0.0132, down 93.62% from ¥0.2069 year-on-year[8] - Operating revenue fell by 40.33% to ¥735,873,844.81 compared to ¥1,233,224,878.97 due to decreased product sales impacted by the pandemic[16] - Net profit attributable to the parent company decreased by 93.60% to ¥7,695,081.96 from ¥120,177,826.39, primarily due to reduced sales revenue[16] - Operating profit decreased by 93.47% to ¥8,955,121.33 from ¥137,160,095.63, reflecting the impact of lower sales revenue[16] - The company reported a net profit of 64.92 million yuan for the first quarter of 2020, reflecting a decrease compared to the previous year[22] - The company reported a total profit of CNY 9,100,340.38 for Q1 2020, a decrease of 93.36% compared to CNY 136,920,069.52 in the previous year[47] Cash Flow - The net cash flow from operating activities was ¥31,353,049.02, a decrease of 53.44% from ¥67,332,847.17 in the same period last year[8] - Cash and cash equivalents decreased by 36.26% to ¥920,858,083.84 from ¥1,444,598,747.72[16] - Net cash flow from operating activities decreased by 53.44% to ¥31,353,049.02 from ¥67,332,847.17, driven by reduced cash receipts from sales[16] - Financing cash flow increased by 202.14% to ¥74,047,471.79 from ¥24,507,654.80, primarily due to increased bank borrowings[16] - The cash and cash equivalents at the end of the period amounted to CNY 107,970,571.39, compared to CNY 276,051,639.69 at the end of the previous year[56] - The company reported a net cash outflow of CNY 3,736,011.82 in cash and cash equivalents for the period[59] - The total cash inflow from operating activities was CNY 249,020,937.81, significantly lower than CNY 797,532,881.73 in the previous year[58] Assets and Liabilities - Total assets at the end of the reporting period were ¥13,334,116,351.55, a decrease of 2.97% from ¥13,742,725,617.23 at the end of the previous year[8] - The total current assets decreased from CNY 7.343 billion at the end of 2019 to CNY 6.930 billion by March 31, 2020, representing a decline of approximately 5.63%[36] - The total liabilities decreased from CNY 9.078 billion at the end of 2019 to CNY 8.663 billion, a decline of about 4.59%[38] - The company's total liabilities decreased to CNY 6,000,354,878.31 from CNY 6,170,675,016.98, a decline of 2.8%[43] - The company's inventory increased from CNY 1.016 billion to CNY 1.162 billion, an increase of approximately 14.36%[36] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 39,113[12] - The largest shareholder, Nanjing First Pesticide Group Co., Ltd., held 45.84% of the shares, amounting to 266,204,031 shares[12] - The net assets attributable to shareholders at the end of the reporting period were ¥4,586,080,822.27, an increase of 0.22% from ¥4,575,937,859.63 at the end of the previous year[8] - The total equity attributable to shareholders increased slightly to CNY 4,586,080,822.27 from CNY 4,575,937,859.63, showing a growth of 0.2%[42] Non-Recurring Items and Commitments - The company reported non-recurring gains of ¥54,755,593.28 during the reporting period[9] - The company has commitments from Jiangsu Hongtai Pharmaceutical Group to ensure that the audited net profits for 2018, 2019, and 2020 will not be less than 100 million yuan, 84.77 million yuan, and 64.49 million yuan respectively[22] - The company has commitments from its controlling shareholder to maintain independence in operations and finances[21] - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[29] Operational Insights - The company did not report any significant new product developments or market expansions during this quarter[60] - The financial report for Q1 2020 was not audited, indicating potential limitations in the reliability of the data presented[61]